Cover Image
市場調查報告書

呼吸吸入器的全球市場 - 估算與預測

Global Respiratory Inhalers Market Research Report - Forecast to 2023

出版商 Market Research Future 商品編碼 516601
出版日期 內容資訊 英文 111 Pages
訂單完成後即時交付
價格
Back to Top
呼吸吸入器的全球市場 - 估算與預測 Global Respiratory Inhalers Market Research Report - Forecast to 2023
出版日期: 2017年11月30日 內容資訊: 英文 111 Pages
簡介

本報告以呼吸吸入器的全球市場為焦點,提供交易額的轉變之估算·預測,以及影響其發展的推動·阻礙因素,發展機會,課題,競爭環境之分析·考察。

第1章 報告序文

第2章 市場簡介

  • 定義
  • 調查範圍
  • 調查目的
  • 前提與法規
  • 市場結構

第3章 調查方法

  • 調查流程
  • 直接取材
  • 二次資訊收集

第4章 市場動態

  • 簡介
  • 市場推動要素
  • 阻礙因素
  • 機會
  • 課題

第5章 市場係數分析

  • 波特的五力分析模型

第6章 呼吸吸入器的全球市場 - 不同形態

  • 簡介
  • 手動型吸入器
  • 數位操作型吸入器

第7章 呼吸吸入器的全球市場 - 各產品

  • 簡介
  • 乾粉吸入劑
  • 定量噴霧吸入器

第8章 呼吸吸入器的全球市場 - 各用途

  • 簡介
  • 氣喘
  • 慢性阻塞性肺病(COPD)

第9章 呼吸吸入器的全球市場 - 各終端用戶

  • 簡介
  • 醫院,診療所
  • 呼吸系統治療中心

第10章 呼吸吸入器的全球市場 - 各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他西歐各國
    • 東歐各國
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 其他亞太地區各國
  • 中東·非洲
    • 中東各國
    • 非洲各國

第11章 競爭環境

  • 各企業佔有率分析

第12章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Respiratory inhalers are the devices which are used to control the respiratory conditions by directly inhaling the drug into the respiratory tract. Respiratory inhalers are used to assist a patient encountering breathing problems resulting from respiratory disorders such as fibrosis, asthma, COPD and ARDS and others.

The global respiratory inhalers market is expected to reach USD 33,572.9 Million by 2023 at a CAGR of 6.1% during the forecast period.

Globally, on the basis of type, manually operated inhalers account for the largest market share of 89.9%, of the market in 2016. The massive share is majorly attributed to the widespread availability and use of the conventional inhaler devices and the lack of awareness and the lesser availability of the digital and smart inhaler devices in all parts of the world. However, the market is changing and Digital inhalers & smart inhaler segment will show a rapid growth globally after 2018.

Globally, On the basis of application, COPD will be the fastest growing application segment growing at a CAGR of 6.5% from 2017 to 2023, as the number of COPD patients is on the rise and patients need a concrete treatment method to counter the disease. Moreover, many awareness programs and campaigns have been started in the last few years in the developing regions such as Asia-Pacific and Middle East & Africa.

Dry Powder Inhalers segment accounted for the largest market share of North America respiratory inhalers market, by product, registering revenue of USD 3,969.6 million in 2016 and expected to reach USD 6,421.0 million by 2023. In North America, metered dose inhalers is the fastest growing segment, and is expected to grow at the CAGR of 6.7% during forecasted period. Dry Powder Inhaler segment being available widespread dominated the market in most of the countries such as US, Germany, France, UK, India, China, Australia, Middle East, and Republic of Korea among others. Apart from these two,

North America commands largest market share of 35.1%, minting USD 7,237.8 million in 2016. European market is second largest after North America with 33.3% market share. Globally, Asia-Pacific region is one of the fastest growing markets for Respiratory Inhalers. It was valued at USD 4,628.5 million in 2016, and is expected to reach USD 7,841.3 million by 2023, at the rate of 6.7% during the forecast period.

Key Players

The leading market players in the global respiratory inhalers market include Adherium Limited, AstraZeneca PLC, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GlaxoSmithKline PLC, Propeller Health, and Teva Pharmaceutical Industries Ltd.

Study objectives of Respiratory Inhalers market

Ø To provide insights about factors influencing and affecting the market growth

Ø To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets

Ø To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.

Ø To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market

Target Audience

  • Medical devices manufacturers
  • Medical devices distributors
  • Pharmaceutical companies
  • Hospitals & Clinics
  • Potential investors
  • Key executive (CEO and COO) and strategy growth manager

Key Findings

  • Metered Dose Inhalers will be the fastest growing product segment growing at a CAGR of 6.5% from 2017 to 2023
  • COPD will be the fastest growing Application segment growing at a CAGR of 6.5% from 2017 to 2023
  • North America held the largest market share of 35.1% in 2016, while Asia-Pacific is expected to register fastest growth of 6.7% CAGR during the forecast period.
  • Asia-Pacific market is expected to reach by USD 7,841.3 million by 2023.

The reports also cover country level analysis:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Western Europe
  • Eastern Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Republic of Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Middle East
  • Africa

Table of Contents

Table of Contents:

1 Report Prologue

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of Study
  • 2.3 Research Objective
  • 2.4 Assumptions & Limitations
    • 2.4.1 Assumptions
    • 2.4.2 Limitations
  • 2.5 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research

4 Market Dynamics

  • 4.1 Introducton
  • 4.2 Drivers
    • 4.2.1 Rising prevalence of chronic respiratory disease
    • 4.2.2 Increasing usage of combination therapy
    • 4.2.3 Growing need for rescue medication
    • 4.2.4 Technological advancements
  • 4.3 Restraints
    • 4.3.1 No single, effective device for every respiratory disorders
    • 4.3.2 Side effects and complications during inhalation
    • 4.3.3 High price
    • 4.3.4 Non-standardized dosage
  • 4.4 Opportunities
    • 4.4.1 Advanced products
    • 4.4.2 Increasing demand in developing countries
  • 4.5 Challenges
    • 4.5.1 Strong competition
    • 4.5.2 More advanced products

5 Market Factor Analysis

  • 5.1 Porter's Five Forces Model
    • 5.1.1 Bargaining power of suppliers
    • 5.1.2 Bargaining Power of Buyers
    • 5.1.3 Threat of New Entrants
    • 5.1.4 Threat of Substitutes
    • 5.1.5 Intensity of Rivalry

6 Global Respiratory Inhalers Market, By Type

  • 6.1 Introduction
  • 6.2 Manually Operated Inhaler
  • 6.3 Digitally Operated Inhaler

7 Global Respiratory Inhalers Market, By Product

  • 7.1 Introduction
  • 7.2 Dry Powder Inhaler
  • 7.3 Metered Dose Inhaler

8 Global Respiratory Inhalers Market, By Application

  • 8.1 Introduction
  • 8.2 Asthma
  • 8.3 COPD

9 Global Respiratory Inhalers Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Respiratory Care Centers

10 Global Respiratory Inhalers Market, By Region

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 France
    • 10.3.3 U.K.
    • 10.3.4 Italy
    • 10.3.5 Spain
    • 10.3.6 Rest of Western Europe
    • 10.3.7 Eastern Europe
  • 10.4 Asia-Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Republic of Korea
    • 10.4.5 Rest of Asia-Pacific
  • 10.5 Middle East & Africa
    • 10.5.1 Middle East
    • 10.5.2 Africa

11 Competitive Landscape

  • 11.1 Company Share Analysis

12 Company Profiles

  • 12.1 Adherium
    • 12.1.1 Company Overview
    • 12.1.2 Product/Business Overview
    • 12.1.3 Adherium Health: Financials
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
  • 12.2 AstraZeneca
    • 12.2.1 Company Overview
    • 12.2.2 Product overview
    • 12.2.3 Financial Overview
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
  • 12.3 Boehringer Ingelheim GmbH
    • 12.3.1 Company Overview
    • 12.3.2 Product Overview
    • 12.3.3 Financial Overview
    • 12.3.4 Key Development
    • 12.3.5 SWOT Analysis
  • 12.4 Chiesi Farmaceutici S.p.A.
    • 12.4.1 Company Overview
    • 12.4.2 Product Overview
    • 12.4.3 Financial Overview
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
  • 12.5 GlaxoSmithKline
    • 12.5.1 Company Overview
    • 12.5.2 Product overview
    • 12.5.3 Financial Overview
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
  • 12.6 Propeller Health
    • 12.6.1 Company Overview
    • 12.6.2 Product Overview
    • 12.6.3 Propeller Health: Financials
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
  • 12.7 Teva Pharmaceutical Industries Ltd
    • 12.7.1 Company Overview
    • 12.7.2 Product Overview
    • 12.7.3 Financial Overview
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis

List of Tables

List of Tables:

  • TABLE 1 GLOBAL RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 2 GLOBAL MANUALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 3 GLOBAL DIGITALLY OPERATED INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 4 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 5 GLOBAL DRY POWDER INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 6 GLOBAL METERED DOSE INHALER MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 7 GLOBAL RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 8 GLOBAL RESPIRATORY INHALER MARKET FOR ASTHMA, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 9 GLOBAL RESPIRATORY INHALER MARKET FOR COPD, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 10 GLOBAL RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 11 GLOBAL RESPIRATORY MARKET FOR HOSPITAL, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 12 GLOBAL RESPIRATORY INHALER MARKET FOR RESPIRATORY CARE CENTERS, BY REGION, 2014-2023 (USD MILLION) 39
  • TABLE 13 GLOBAL RESPIRATORY INHALERS MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 14 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
  • TABLE 15 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 16 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 17 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 18 NORTH AMERICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 19 US RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 20 US RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 21 US RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 22 US RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 23 CANADA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 24 CANADA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 25 CANADA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 26 CANADA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 27 EUROPE RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
  • TABLE 28 EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 29 EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 30 EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 31 EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 32 GERMANY RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 33 GERMANY RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 34 GERMANY RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 35 GERMANY RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 36 FRANCE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 37 FRANCE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 38 FRANCE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 39 FRANCE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 40 U.K. RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 41 U.K. RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 42 U.K. RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 43 U.K. RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 44 ITALY RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 45 ITALY RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 46 ITALY RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 47 ITALY RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 48 SPAIN RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 49 SPAIN RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 50 SPAIN RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 51 SPAIN RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 52 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 53 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 54 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 55 REST OF WESTERN EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 56 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 57 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 58 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 59 EASTERN EUROPE RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 60 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY COUNTRY, 2014-2023 (USD MILLION)
  • TABLE 61 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 62 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 63 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 64 ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 65 JAPAN RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 66 JAPAN RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 67 JAPAN RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 68 JAPAN RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 69 CHINA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 70 CHINA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 71 CHINA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 72 CHINA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 73 INDIA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 74 INDIA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 75 INDIA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 76 INDIA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 77 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 78 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 79 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 80 REPUBLIC OF KOREA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 81 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 82 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 83 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 84 REST OF ASIA-PACIFIC RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 85 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY REGION, 2014-2023 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 88 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 89 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 90 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 91 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 92 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 93 MIDDLE EAST RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 94 AFRICA RESPIRATORY INHALERS MARKET, BY TYPE, 2014-2023 (USD MILLION)
  • TABLE 95 AFRICA RESPIRATORY INHALERS MARKET, BY PRODUCT, 2014-2023 (USD MILLION)
  • TABLE 96 AFRICA RESPIRATORY INHALERS MARKET, BY APPLICATION, 2014-2023 (USD MILLION)
  • TABLE 97 AFRICA RESPIRATORY INHALERS MARKET, BY END USER, 2014-2023 (USD MILLION)
  • TABLE 98 ADHERIUM: KEY DEVELOPMENTS
  • TABLE 99 ASTRAZENECA: PRODUCT OVERVIEW
  • TABLE 100 ASTRAZENECA: KEY DEVELOPMENTS
  • TABLE 101 BOEHRINGER INGELHEIM GMBH: PRODUCT OVERVIEW
  • TABLE 102 BOEHRINGER INGELHEIM GMBH: KEY DEVELOPMENTS
  • TABLE 103 CHIESI FARMACEUTICI S.P.A: PRODUCT OVERVIEW
  • TABLE 104 CHIESI FARMACEUTICI S.P.A: KEY DEVELOPMENTS
  • TABLE 105 GLAXOSMITHKLINE PLC: PRODUCT OVERVIEW
  • TABLE 106 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS
  • TABLE 107 PROPELLER HEALTH: PRODUCT/SERVICES OVERVIEW
  • TABLE 108 PROPELLER HEALTH: KEY DEVELOPMENTS
  • TABLE 109 TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT FINANCIALS
  • TABLE 110 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS

List of Figures

List of Figures:

  • FIGURE 1 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY TYPE, 2016 (%)
  • FIGURE 2 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY PRODUCT, 2016 (%)
  • FIGURE 3 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY APPLICATION, 2016 (%)
  • FIGURE 4 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY END USER, 2016 (%)
  • FIGURE 5 GLOBAL RESPIRATORY INHALER MARKET SHARE, BY REGION, 2016 (%)
  • FIGURE 6 MARKET STRUCTURE OF GLOBAL RESPIRATORY INHALER MARKET
  • FIGURE 7 RESEARCH PROCESS OF MRFR
  • FIGURE 8 DROC OF GLOBAL RESPIRATORY INHALERS MARKET
  • FIGURE 9 PORTERS FIVE FORCES MODEL
  • FIGURE 10 GLOBAL RESPIRATORY INHALERS MARKET, BY TYPE, 2016 & 2023 (USD MILLION)
  • FIGURE 11 GLOBAL RESPIRATORY INHALERS MARKET, BY PRODUCT, 2016 & 2023
  • FIGURE 12 GLOBAL RESPIRATORY INHALERS MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION)
  • FIGURE 13 GLOBAL RESPIRATORY INHALERS MARKET, BY END USER, 2016 & 2023 (USD MILLION)
  • FIGURE 14 GLOBAL RESPIRATORY INHALERS MARKET SHARE, BY REGION, 2016 (%)
  • FIGURE 15 NORTH AMERICA RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)
  • FIGURE 16 EUROPE RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)
  • FIGURE 17 ASIA-PACIFIC RESPIRATORY INHALERS MARKET SHARE, BY COUNTRY, 2016 (%)
  • FIGURE 18 MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET, BY REGION, 2016 (%)
  • FIGURE 19 GLOBAL RESPIRATORY INHALER MARKET: COMPANY SHARE ANALYSIS, 2016 (%)
  • FIGURE 20 ADHERIUM: SWOT ANALYSIS
  • FIGURE 21 ASTRAZENECA: RECENT FINANCIAL
  • FIGURE 22 ASTRAZENECA: GEOGRAPHICAL MIX, 2016 (%)
  • FIGURE 23 ASTRAZENECA: OPERATING SEGMENTS, 2016 (%)
  • FIGURE 24 ASTRAZENECA: RESPIRATORY SEGMENT MIX, 2016 (%)
  • FIGURE 25 ASTRAZENECA: SWOT ANALYSIS
  • FIGURE 26 BOEHRINGER INGELHEIM GMBH: RECENT FINANCIALS
  • FIGURE 27 BOEHRINGER INGELHEIM GMBH: GEOGRAPHICAL MIX, 2016 (%)
  • FIGURE 28 BOEHRINGER INGELHEIM GMBH: OPERATING SEGMENTS, 2016 (%)
  • FIGURE 29 BOEHRINGER INGELHEIM GMBH: SWOT ANALYSIS
  • FIGURE 30 CHIESI FARMACEUTICI S.P.A: RECENT FINANCIALS
  • FIGURE 31 CHIESI FARMACEUTICI S.P.A: GEOGRAPHICAL MIX, 2015 (%)
  • FIGURE 32 CHIESI FARMACEUTICI S.P.A: RESPIRATORY SEGMENT MIX, 2016 (USD MILLION)
  • FIGURE 33 CHIESI FARMACEUTICI S.P.A: SWOT ANALYSIS
  • FIGURE 34 GLAXOSMITHKLINE: RECENT FINANCIALS
  • FIGURE 35 GLAXOSMITHKLINE PLC: GEOGRAPHICAL MIX, 2016 (%)
  • FIGURE 36 GLAXOSMITHKLINE PLC: OPERATING SEGMENTS, 2016 (%)
  • FIGURE 37 GLAXOSMITHKLINE PLC: PHARMACEUTICAL BUSINESS MIX, 2016 (%)
  • FIGURE 38 GLAXOSMITHKLINE: SWOT ANALYSIS
  • FIGURE 39 PROPELLER HEALTH: SWOT ANALYSIS
  • FIGURE 40 TEVA PHARMACEUTICAL INDUSTRIES LTD: GEOGRAPHICAL MIX, 2016 (%)
  • FIGURE 41 TEVA PHARMACEUTICAL INDUSTRIES LTD: OPERATING SEGMENTS, 2016 (%)
  • FIGURE 42 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS
Back to Top